🟠 Moderate Evidence
The oral cholera vaccine Euvichol® provided significant protection against cholera infection five years after initial vaccination during Haiti’s devastating outbreak, according to a new case-control study published in The Lancet Regional Health – Americas. The study found that any vaccination with the two-dose regimen reduced cholera risk by 61% even after five years, providing crucial evidence for long-term vaccine effectiveness in outbreak settings.
Key takeaways
- Euvichol® oral cholera vaccine showed 61% effectiveness against cholera 5 years post-vaccination in Haiti
- The study analyzed data from 2016-2018 cholera outbreak in rural Artibonite department
- Findings support extended protection periods for oral cholera vaccines in endemic settings
Study at a Glance
| Source | The Lancet Regional Health – Americas |
| Study type | Case-control study |
| Sample size | N = 1,247 participants |
| Population | Rural Haitian communities affected by cholera outbreak |
| Country | Haiti |
Cholera vaccine effectiveness over time
Protection levels of oral cholera vaccine in Haiti, 2016-2018
Source: The Lancet Regional Health – Americas, 2026 | Georgian Medical Journal News
Vaccine maintains protection during major outbreak
The research examined vaccine effectiveness during a significant cholera outbreak that struck rural Haiti’s Artibonite department between 2016 and 2018, approximately five years after the initial World Health Organization-supported vaccination campaign. The case-control study included 1,247 participants from communities that had received the two-dose Euvichol® vaccination series in 2012-2013.
Researchers found that individuals who had received any doses of the vaccine during the original campaign showed a 61% reduced risk of developing cholera compared to unvaccinated individuals during the outbreak period. This protection level exceeded expectations for a five-year timeframe, particularly given the challenging environmental conditions and continued cholera transmission in the region.
Implications for global cholera control strategies
The findings have significant implications for global cholera control efforts, particularly regarding vaccination scheduling and booster dose timing. Current World Health Organization guidelines recommend considering booster doses after two to three years in high-risk populations, but this study suggests protection may extend longer than previously documented.
The research comes as global cholera vaccine supplies face severe shortages, with the WHO reporting increased outbreak frequency across multiple countries. Understanding the duration of vaccine protection is crucial for optimizing limited vaccine resources and developing effective public health strategies.
Any vaccination with Euvichol® provided 61% protection against cholera infection five years after the initial two-dose campaign in rural Haiti
— Study authors, The Lancet Regional Health – Americas (2026)
Study limitations and future research needs
The researchers acknowledged several limitations in their analysis, including potential recall bias regarding vaccination status and the observational nature of the case-control design. The study was conducted in a specific geographic and epidemiological context, which may limit generalizability to other cholera-endemic regions with different transmission patterns.
Future research priorities include conducting randomized controlled trials to confirm long-term vaccine effectiveness and investigating optimal booster schedules for different population groups. The authors emphasized the need for continued surveillance in Haiti and other cholera-affected regions to monitor vaccine performance over extended periods.
What this means
Frequently asked questions
How long does oral cholera vaccine protection last?
This study found 61% protection remained after 5 years in Haiti. Protection duration may vary by region, population, and continued cholera exposure levels.
Should people get cholera vaccine boosters?
Current WHO guidelines suggest considering boosters after 2-3 years in high-risk areas. This study suggests protection may last longer, but individual circumstances should guide decisions.
Is the cholera vaccine effective during outbreaks?
Yes, this study demonstrated significant protection even during an active cholera outbreak five years after initial vaccination. Vaccination remains a key outbreak control measure.
These findings provide valuable evidence for cholera prevention strategies as global health officials work to address increasing outbreak frequency and vaccine supply challenges. The demonstrated long-term effectiveness of oral cholera vaccination supports its continued use as a critical tool for protecting vulnerable populations in cholera-endemic regions.
Was this article helpful?
Related Coverage
